Ligands with its PDB code and its tanimoto calculated from the molecule, present in the database, which has for MMscode: MMs02452133

Ligand	Ligand name	Chain	PDB	Tanimoto
DTX	DIGITOXIGENIN	A	1LNM	0.76
CBO	CARBENOXOLONE	A,B,C,D	1HDC	0.73
CBO	CARBENOXOLONE	A,B,C,D	2BEL	0.73
TES	TESTOSTERONE	A	1JTV	0.77
TES	TESTOSTERONE	A	2Q7L	0.77
TES	TESTOSTERONE	A	2Q7I	0.77
TES	TESTOSTERONE	A,B	1J96	0.77
TES	TESTOSTERONE	A	2Q7K	0.77
TES	TESTOSTERONE	A,B	1Q13	0.77
TES	TESTOSTERONE	H	1I9J	0.77
TES	TESTOSTERONE	A,B	1AFS	0.77
TES	TESTOSTERONE	H	1VPO	0.77
TES	TESTOSTERONE	A	2Q7J	0.77
TES	TESTOSTERONE	A,B	3BUR	0.77
TES	TESTOSTERONE	A	2AM9	0.77
OCC	2ALPHA-(3-HYDROXYPROPOXY)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAR	0.7
VDZ	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RJK	0.71
CLL	CHOLESTERYL LINOLEATE	A,B	1CLE	0.9
MVD	2ALPHA-METHYL-1ALPHA,25-DIHYDROXY-VITAMIN D3	A	2HB8	0.71
0MA	maslinic acid	A	2QN2	0.72
HCR	7-HYDROXYCHOLESTEROL	A	1ZHT	0.81
DOG	DIGOXIGENIN	A	1LKE	0.76
VD3	(1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL	A	2GJ5	0.73
VD3	(1S,3Z)-3-[(2E)-2-[(1R,3AR,7AS)-7A-METHYL-1-[(2R)-6-METHYLHEPTAN-2-YL]-2,3,3A,5,6,7-HEXAHYDRO-1H-INDEN-4-YLIDENE]ETHYLIDENE]-4-METHYLIDENE-CYCLOHEXAN-1-OL	A,B	3C6G	0.73
DL7	(5beta,14beta,17alpha,25R)-3-oxocholest-7-en-26-oic acid	A	3GYU	0.81
C33	2ALPHA-PROPYL-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAM	0.71
GR3	3-ACETOXY-17-(1-FORMYL-5-METHYL-3-OXO-HEX-4-ENYL)-16-HYDROXY-4,10,13,14-TETRAMETHYL-2,3,4,5,6,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHRENE-4-CARBOXYLIC ACID	B,D	1AWH	0.75
ERG	ERGOSTEROL	A	1BXM	0.79
ERG	ERGOSTEROL	A	1ZHZ	0.79
ERG	ERGOSTEROL	A,B	2AIB	0.79
SNL	SPIRONOLACTONE	A,B	2AB2	0.72
SNL	SPIRONOLACTONE	A,B,C,D,E,F	2OAX	0.72
DL4	(14beta,17alpha,25R)-3-oxocholest-4-en-26-oic acid	A	3GYT	0.78
PLO	(3BETA)-3-HYDROXYPREGN-5-EN-20-ONE	A	1Q20	0.8
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZBZ	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1RK3	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1DB1	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE9	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2HC4	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	2ZLC	0.71
VDX	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	3CV9	0.71
1CA	DESOXYCORTICOSTERONE	A,B	1Y9R	0.74
1CA	DESOXYCORTICOSTERONE	A,B,C	2ABI	0.74
1CA	DESOXYCORTICOSTERONE	A	2Q3Y	0.74
1CA	DESOXYCORTICOSTERONE	A	2AA7	0.74
HC2	20-HYDROXYCHOLESTEROL	A	1ZHW	0.83
CO1	17-[3-(3,3-DIMETHYL-OXIRANYL)-1-METHYL-PROPYL]-10,13-DIMETHYL-2,3,4,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-3-OL	A,B	1P8D	0.83
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	1SQN	0.7
NDR	(14beta,17alpha)-17-ethynyl-17-hydroxyestr-4-en-3-one	A,B	2W8Y	0.7
SIH	PROGESTERONE-11-ALPHA-OL-HEMISUCCINATE	H	1DBM	0.8
2OB	CHOLESTERYL OLEATE	A	2OBD	0.9
VD2	5-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-2-METHYL-CYCLOHEXANE-1,3-DIOL	A	1RKH	0.73
HC3	25-HYDROXYCHOLESTEROL	A	1ZHX	0.83
KH1	5-(2-{1-[1-(4-ETHYL-4-HYDROXY-HEXYLOXY)-ETHYL]-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE}-ETHYLIDENE)-4-METHYLENE-CYCLOHEXANE-1,3-DIOL	A	1IE8	0.72
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A	1LHV	0.7
NOG	13-BETA-ETHYL-17-ALPHA-ETHYNYL-17-BETA-HYDROXYGON-4-EN-3-ONE	A,B	3D90	0.7
0AS	asiatic acid	A	2QN1	0.72
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A,B	1E3R	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	3DHE	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1J99	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1COY	0.79
AND	3-BETA-HYDROXY-5-ANDROSTEN-17-ONE	A	1Q22	0.79
JB1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2R,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXM	0.72
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,B	1J78	0.76
VDY	3-{2-[1-(5-HYDROXY-1,5-DIMETHYL-HEXYL)-7A-METHYL-OCTAHYDRO-INDEN-4-YLIDENE]-ETHYLIDENE}-4-METHYLENE-CYCLOHEXANOL	A,D	1MZ9	0.76
LAN	LANOSTEROL	A	1W6K	0.78
NTH	SUCCINIC ACID MONO-(13-METHYL-3-OXO-2,3,6,7,8,9,10,11,12,13,14,15,16,17-TETRADECAHYDRO-1H-CYCLOPENTA[A]PHENANTHREN-17-YL) ESTER	A,B	1BUQ	0.8
CLR	CHOLESTEROL	A,B	2ZXE	0.83
CLR	CHOLESTEROL	A	1N83	0.83
CLR	CHOLESTEROL	A	2RH1	0.83
CLR	CHOLESTEROL	A	1LRI	0.83
CLR	CHOLESTEROL	A	1ZHY	0.83
CLR	CHOLESTEROL	A	3D4S	0.83
FUA	FUSIDIC ACID	A	1QCA	0.76
FUA	FUSIDIC ACID	A,B,C,D,E,F,G,H,I,J,K,L	1Q23	0.76
FUA	FUSIDIC ACID	A,B	2VUF	0.76
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPG	0.77
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPJ	0.77
FFA	(10ALPHA,13ALPHA,14BETA,17ALPHA)-17-HYDROXYANDROST-4-EN-3-ONE	A,B	2IPF	0.77
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A	1S0X	0.82
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A	2Q9F	0.82
C3S	CHOLEST-5-EN-3-YL HYDROGEN SULFATE	A,B,C	2HKA	0.82
C0R	CORTICOSTERONE	A	2A3I	0.73
C0R	CORTICOSTERONE	A,B	1Y5R	0.73
O1C	2ALPHA-(3-HYDROXYPROPYL)-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HB7	0.7
TH2	TESTOSTERONE HEMISUCCINATE	A,B	2CBT	0.81
TH2	TESTOSTERONE HEMISUCCINATE	A,B,C,D,E,F	2CBQ	0.81
TH2	TESTOSTERONE HEMISUCCINATE	A	2CBO	0.81
D2V	(3S,5Z,7E,22E)-9,10-secoergosta-5,7,10,22-tetraen-3-ol	A,B	3CZH	0.72
ATE	16,17-ANDROSTENE-3-OL	A,B	1XNX	0.71
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A,B	2VDY	0.7
HCY	(11alpha,14beta)-11,17,21-trihydroxypregn-4-ene-3,20-dione	A	2V95	0.7
C3O	2ALPHA-PROPOXY-1ALPHA,25-DIHYDROXYVITAMIN D3	A	2HAS	0.7
CBW	(3BETA,5BETA,14BETA)-3-HYDROXY-11-OXOOLEAN-12-EN-29-OIC ACID	A	2W4Q	0.73
JC1	(1R,3S,5Z)-5-[(2E)-2-[(1R,3aS,7aR)-1-[(2S,3S)-3-(2-hydroxyethyl)heptan-2-yl]-7a-methyl-2,3,3a,5,6,7-hexahydro-1H-inden-4-ylidene]ethylidene]-4-methylidene-cyclohexane-1,3-diol	A	2ZXN	0.72